Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Appointment of Daniel J. Levangie to Board

August 31, 2021
RNS Number : 1082K Renalytix PLC 31 August 2021     Renalytix plc (" Renalytix " or the " Company ")     Renalytix Appoints Daniel J. Levangie to its Board of Directors   Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation

Peer reviewed publication

August 26, 2021
RNS Number : 8163J Renalytix PLC 26 August 2021   Renalytix plc (" Renalytix " or the " Company ")     Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX TM Testing at Primary Care Level   Peer reviewed publication in Journal of Medical Economics supports payer coverage for

Director/PDMR Shareholding

August 13, 2021
RNS Number : 6311I Renalytix PLC 13 August 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 13 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000

Director/PDMR Dealing

August 6, 2021
RNS Number : 9108H Renalytix PLC 06 August 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 6 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000

Total Voting Rights

August 2, 2021
RNS Number : 2696H Renalytix PLC 02 August 2021   Renalytix plc   (" Renalytix " or the " Company ")     Total voting rights   New York , 2 August 2021 - Renalytix (LSE: RENX) announces that t he Company's total issued share capital consists of 72,229,786   shares of 0.25 pence each, with each

Director/PDMR Dealing

July 30, 2021
RNS Number : 1332H Renalytix PLC 30 July 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 30 July 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O . James Sterling , the Company's Chief Financial Officer, of 12,000

Appointment of Ann Berman to Board of Directors

July 28, 2021
RNS Number : 6767G Renalytix PLC 28 July 2021     Renalytix Appoints Ann Berman to its Board of Directors   Berman serves on the board of Lowes Corporation , is a member of the board of trustees of Beth Israel Deaconess , and is a former chief financial officer of Harvard University     NEW YORK

Director/PDMR Shareholding

July 23, 2021
RNS Number : 3061G Renalytix PLC 23 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 23 July 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000

VP of Global Quality and Regulatory Appointment

July 22, 2021
RNS Number : 0685G Renalytix PLC 22 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory   Hutson To Build-on Renalytix Quality and Regulatory Strategy for KidneyIntelX Global Commercialization   NEW YORK

Exercise of Options and TVR

July 19, 2021
RNS Number : 7167F Renalytix PLC 19 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Exercise of Options and TVR   NEW YORK , 19 July, 2021 - Renalytix plc (AIM: RENX) announces that it has issued and allotted 5,000 ordinary shares of 0.25 pence each in the share capital of the
Displaying 31 - 40 of 183